Circadian regulation of central ethanol sensitivity by the mPer2 gene

Authors: Perreau-Lenz, Stéphanie; Zghoul, Tarek1; de Fonseca, Fernando R.2; Spanagel, Rainer1; Bilbao, Ainhoa1

Source: Addiction Biology, Volume 14, Number 3, July 2009 , pp. 253-259(7)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

The effect of alcohol is known to vary with the time of the day. Although initially it was suggested that this phenomenon may be due to diurnal differences in ethanol metabolism, more recent studies were contradicting. In the present study, we therefore first set out in assessing the diurnal variations in ethanol sensitivity in mice analysing, concurrently, ethanol elimination rates. Ethanol-induced (3.5 g/kg; intraperitoneal) loss of righting reflex (LORR) duration was thus determined at several Zeitgeber time (ZT) points (ZT5, 11, 17 and 23) in C57BL/6N mice. In parallel, the corresponding ethanol elimination rates were also assessed. The results display the existence of a distinct diurnal rhythm in LORR duration peaking at ZT11, whereas no differences could be observed regarding the elimination rates of alcohol. Successively, we checked the involvement of the clock genes mPer1 and mPer2 in conveying this rhythm in sensitivity, testing LORR and hypothermia at the peak and trough previously observed (ZT5 and ZT11). Per1Brdm1 mice demonstrate a similar diurnal pattern as control mice, with enhanced LORR durations at ZT11. In contrast, Per2Brdm1 mice did not exhibit a temporal variation to the depressant effects of ethanol with respect to LORR, revealing a constant high sensitivity to ethanol. The present study reveals a central role of the mPer2 gene in inhibiting alcohol sensitivity at the beginning of the inactive phase.

Keywords: Clock genes; ethanol metabolism; ethanol sensitivity; loss of righting reflex; mice; Per genes

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1369-1600.2009.00165.x

Affiliations: 1: Department of Psychopharmacology, Central Institute of Mental Health, University of Heidelberg, Germany and 2: Fundación IMABIS, Neuropharmacology, Hospital Carlos Haya, Malaga, Spain

Publication date: 2009-07-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page